Literature DB >> 4104722

Australia antigen in urine.

K Apostolov, D J Bauer, J W Selway, R A Fox, F J Dudley, S Sherlock.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4104722     DOI: 10.1016/s0140-6736(71)91784-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  HBs antigenemia in renal allograft recipients.

Authors:  R N Fine; M H Malekzadeh; A J Pennisi; C H Uittenbogaart; R B Ettenger; B H Landing; H T Wright
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

Review 2.  Serum hepatitis as a persistent infection.

Authors:  Y E Cossart
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

Review 3.  Long-incubation (virus B, HAA-associated) hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

4.  Screening for transmission of hepatitis within a liver unit.

Authors:  P Bentley; D Haynes; P Sharpstone; P E Taylor; A J Zuckerman; R Williams
Journal:  J Hyg (Lond)       Date:  1972-03

5.  Practical guidelines for assessing patients positive for hepatitis B surface antigen.

Authors:  S V Feinman; B Berris; J C Sinclair; D W Wrobel
Journal:  Can Med Assoc J       Date:  1976-11-20       Impact factor: 8.262

6.  Subtypes of hepatitis B antigen among patients and symptomless carriers.

Authors:  H T Green; G C Turner
Journal:  J Hyg (Lond)       Date:  1975-02

7.  Induction of chronic lethal Australia antigen hepatitis in mice.

Authors:  L A Johnson; E Wirostko
Journal:  Am J Pathol       Date:  1976-01       Impact factor: 4.307

8.  Hepatitis B antigen in saliva, urine, and stool.

Authors:  G R Irwin; A M Allen; W H Bancroft; J J Karwacki; H L Brown; R H Pinkerton; M Willhight; F H Top
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

9.  Possible transmission of serum (Australia-antigen-positive) hepatitis via the conjunctiva.

Authors:  M C Kew
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.